| Literature DB >> 35860664 |
YaPing Tao1,2, Cong Wei1, YiMin Su3, Bing Hu1, Di Sun1.
Abstract
Cosmetic skin diseases are a part of many dermatological concerns brought up by patients, which negatively affect mental health and quality of life. Imaging technology has an established role in the diagnosis of cosmetic skin diseases by recognizing information on deep skin lesions. Due to the complex physiological and pathological nature of cosmetic skin diseases, the diagnostic imaging performance varies greatly. Developing noninvasive technology models with wide applicability, particularly high-frequency ultrasound (HFUS), which is able to achieve high-resolution imaging of the skin from the stratum corneum down to the deep fascia, is of great significance to medical cosmetology. To explore the great potential of HFUS in cosmetic skin diseases, a narrative review of literature from PubMed and Web of Science published between 1985 and 2022 was conducted. This narrative review focuses on the progression of HFUS imaging in medical cosmetology, especially on its promising application in the quantitative evaluation and differential diagnosis of cutaneous pathological scar, port wine stain (PWS), acne, skin aging, and other cosmetic applications.Entities:
Keywords: dermatology; high-frequency ultrasound; medical cosmetology; pathological scar; port wine stain
Year: 2022 PMID: 35860664 PMCID: PMC9289277 DOI: 10.3389/fphys.2022.885922
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
Comparison of the advantages and disadvantages among the conventional skin imaging technologies.
| Technology | Advantage | Disadvantage | Applicable disease/purpose (in medical cosmetology) | References |
|---|---|---|---|---|
| Skin photography | Accessible | Unable to display the deep structures | To evaluate the severity and efficacy of volume, damaging skin diseases | ( |
| Dermoscope | To observe the fine outline and color of the lesion surface that is invisible to the naked eyes | Zero imaging depth; unable to display the deep structures | To diagnose and differentiate common skin diseases, and the changes in pigment and blood vessels after cosmetic treatment | ( |
| Reflectance confocal microscopy | To obtain cell level imaging | Only detecting the superficial part of the dermis | To diagnose and differentiate vascular skin diseases, pigmented skin diseases, and acne, and evaluate the curative effect | ( |
| Multispectral optoacoustic tomography | To study the metabolic process at the single cell level | Scanning depth of 200–300 um; unable to show deep lesions | To measure the morphology of normal human skin, characterize skin aging, study skin pharmacokinetics, evaluate the efficacy of medical skin care products | ( |
| Optical coherence tomography | Axial resolution up to 1.0–15.0 μm, can clearly show the morphology of the skin epidermis and dermis | Unable to achieve cell level imaging, or display the variability of deep disease over 2 mm | To monitor the microscopic changes such as photoaging and scar treatment and evaluate the effect of laser treatment | ( |
| High-frequency ultrasound | To display full-thickness skin tissue and deep lesions | Influenced by age, microcirculation changes, edema | To measure the thickness of the normal skin and skin lesions, and monitor the efficacy of laser treatment, minimally invasive treatment and injection cosmetology | ( |
FIGURE 1HFUS identifying the different types of skin scars. (A,E): Hypertroplic scars; (B,F): Keloids; (C,G): Atrophic scars; (D,H): Normal skin. (A–D): The optical characteristics of various scars observed by skin microscopy; (E–H): audio-visual characteristics of scar skin detected by 20 MHz HFUS.
FIGURE 2HFUS assessing the therapeutic efficacy of scars. A keloid before (A) and after (B) intralesional steroids injection. B-mode ultrasound images (longitudinal) of normal skin (C), pretreated keloids (D), and post treated keloids after an intralesional steroid injection (E). (F), (G), and (H) are the corresponding elastography images of (C), (D), and (E), respectively. Images (A) to (H) were captured from the same patient. Arrows in images (D) and (E) showed an obvious reduction in the scar thickness after treatment. The depth × width of the images (C–E) were 1.5 × 2.25, 1.6 × 2.4, and 1.5 × 2.25 (cm), respectively. As shown in the images, the quantitative elasticity values, including Young’s modulus and shear wave velocity, decreased after treatment.
FIGURE 3Color-Doppler ultrasonography evaluates the characteristic vasculature of scars. Photography of a scapular keloid before treatment (A) and after 1 month of treatment with a Pico device (B). B-mode Ultrasound images of the keloid before treatment (C), after 1 month of treatment (D), and after 2 months of treatment with a Pico device (F), show that the keloid thickness was reduced from 0.42 to 0.27 cm and then to 0.23 cm. Color-Doppler ultrasound images showed palisade vessels in the keloid before treatment €, and palisade vessels disappeared after 2 months of treatment with a Pico device (F).
FIGURE 4Scores of the blood flow signals in PWS lesions with Power Doppler ultrasound. (A) Grade 0, absence of color signals in a pink-type lesion; (B) grade 1, mild color signals in a thickened-type lesion; (C) grade 2, moderate color signals in a thickened-type lesion; (D) grade 3, marked color signals in a nodular-type lesion.
FIGURE 5HFUS in identifying the different types of acne. (A) A false cyst-type dermis and subcutaneous tissue within a low-echo nodule; the arrow indicates the rich blood flow around the nodule; (B) The hair follicle type between the two arrows shows a slightly tilted low echo across the dermis; (C) A fistula type low-echo structure of the belt between the two arrows is located in the dermis and subcutaneous tissue layer; (D) The calcification arrow shows the dot calcification stove in the dermis. (d: dermis, st: subcutaneous tissue, m: face muscle).
FIGURE 6Skin photoaging: subcutaneous low-echo band (SLEB) on HFUS images. (A) Photography of the ventral and dorsal areas of the forearm; (B) Decreased dermis echogenicity (arrow) on HFUS image. (C) Discrete degeneration of collagen fibers. Hematoxylin and eosin (H and E) staining (10X). (D) SLEB (arrow) on the HFUS image. (E) Solar elastosis. H and E staining (10X).
FIGURE 7Monitoring complications of esthetic treatments by HFUS imaging. Sagittal plane (A) Hyperechoic lips (arrows); (B) Hypoechogenic area (filler deposit, arrow) surrounded by a hyperechoic region (T-teeth, M-orbicularis muscle, C-cutaneous tissue, Mu-mucosa). Sagittal plane (C) B-mode sonogram: The superior labial artery (left arrow), invisible inferior artery (right arrow); (D) Color Doppler sonogram: visible blood flow of the superior labial artery (left arrow), invisible blood flow of the inferior labial artery (right arrow); (LL: lower lip; UL: upper lip). Transverse plane (E) Color Doppler sonogram: collateral circulation of the left inferior labial artery (arrow).
FIGURE 8HFUS detection of retroocular artery occlusions resulting from cosmetic facial filler injections. Case 1. An ophthalmic artery occlusion caused by a cosmetic autologous fat injection. (A) Fundus photograph displaying diffuse retina edema and segmented retinal arteries; (B) Fundus fluorescein angiography showing severe damage to choroidal and retinal filling; (C) CDFI displaying no retrobulbar blood flow signal; (D) Diffusion weighted image showing a large area of acute infarction in the left posterior temporal lobe and occipital lobe. Case 2. A case of central retinal artery occlusion caused by a cosmetic autologous fat injection. (E) Fundus photograph image showing retinal whitening with a cherry red spot. (F) Optical coherence tomography image indicating inner retinal edema. (G–I) CDFI shows no retrobulbar blood flow signal in the central retinal artery, a slight reduction in the posterior ciliary arteries, and a normal blood flow signal in the ophthalmic artery. Case 3. A case of anterior ischemic optic neuropathy after a hyaluronic acid injection. A fundus showing optic disc edema at baseline (J) and pale optic disc at follow-up (L); (K) CDFI showing a decreased end diastolic velocity and an increased resistance index and pulsatility index of the central retinal artery and a high peak velocity of arterial blood.